Cancers, Free Full-Text

Neuroblastoma is the most common extracranial solid pediatric tumor, with around 15% childhood cancer-related mortality. High-risk neuroblastomas exhibit a range of genetic, morphological, and clinical heterogeneities, which add complexity to diagnosis and treatment with existing modalities. Identification of novel therapies is a high priority in high-risk neuroblastoma, and the combination of genetic analysis with increased mechanistic understanding—including identification of key signaling and developmental events—provides optimism for the future. This focused review highlights several recent findings concerning chromosomes 1p, 2p, and 11q, which link genetic aberrations with aberrant molecular signaling output. These novel molecular insights contribute important knowledge towards more effective treatment strategies for neuroblastoma.

Cancers, Free Full-Text

Kidney Cancer: Symptoms, Signs, Causes & Treatment

Profiling molecular regulators of recurrence in chemorefractory triple-negative breast cancers, Breast Cancer Research

Meta-analysis in metastatic uveal melanoma to determine progression free and overall survival benchmarks: an international rare cancers initiative (IRCI) ocular melanoma study.

Cancers, Free Full-Text

Prostate Cancer: Symptoms, Causes & Treatment

No scientific basis for claims of curing cancer with a sugar-free diet, drinking hot lemon water, and organic coconut oil - FACTLY

Cancer-Free Creations

Noninvasive detection of any-stage cancer using free glycosaminoglycans

PDF) Survival and prognostic factors for survival, cancer specific survival and disease free interval in 239 patients with Hurthle cell carcinoma: A single center experience

Noninvasive detection of any-stage cancer using free glycosaminoglycans

Multimodal analysis of methylomics and fragmentomics in plasma cell-free DNA for multi-cancer early detection and localization